Form 4 for WHWK Whitehawk Therapeutics, Inc.
Accepted 2025-03-04 00:00:00 ET · period of report 2025-03-01 · accession 0001415889-25-006676 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-04 | 2025-03-01 | WHWK | BALL BRYAN | See remarks | M - OptEx | — | +5,000 | 105.0K | +5% | — |
| D | 2025-03-04 | 2025-03-04 | WHWK | BALL BRYAN | See remarks | A - Grant | $2.40 | +100.0K | 202.9K | +97% | +$240.0K |
| D | 2025-03-04 | 2025-03-03 | WHWK | BALL BRYAN | See remarks | S - Sale+OE | $2.35 | -2,147 | 102.9K | -2% | -$5,045 |
| D | 2025-03-04 | 2025-03-01 | WHWK | BALL BRYAN | See remarks | M - OptEx | $0.00 | -5,000 | 15.0K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-01 | M | A | 5,000 | — | 105,000 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock. |
| 2 | Common | Common Stock | 2025-03-04 | A | A | 100,000 | $2.40 | 202,853 | D | — | — | |
| 3 | Common | Common Stock | 2025-03-03 | S | D | 2,147 | $2.35 | 102,853 | D | — | — | |
| 4 | Derivative | Restricted Stock Units | 2025-03-01 | M | D | 5,000 | $0.00 | 15,000 | D | — · — to — | 5,000 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock. (F3) Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter. "Vesting Commencement Date" shall mean March 1, 2024. |